首页> 中文期刊> 《海峡药学》 >血必净注射液在治疗感染性休克的效果及对血清降钙素原(PCT)及CRP水平的影响

血必净注射液在治疗感染性休克的效果及对血清降钙素原(PCT)及CRP水平的影响

         

摘要

目的:探讨血必净注射液在治疗感染性休克的效果及对血清降钙素原( PCT)及CRP水平的影响。方法选取2013年4月~2014年10月我院收治的252例感染性休克作为研究对象,将患者随机分为研究组和对照组,各126例。对照组患者使用常规治疗,观察组患者在常规治疗基础上使用血必净静脉滴注治疗。综合比较两组患者治疗总有效率、治疗前后血清PCT、CRP值及不良反应发生率的差异。结果研究组治疗总有效率为89.7%,显著高于对照组的78.6%(P<0.05);治疗后研究组患者血清PCT、CRP值均显著优于对照组(P<0.05);两组均无严重不良反应( P>0.05)。结论血必净注射液治疗感染性休克疗效确切,可显著降低血清PCT、CRP水平,无严重不良反应。%ABSTRACT:OBJECTIVE To investigate effects of Xuebijing injection for the treatment of septic shock and the influenceofPCTandCRPlevels.METHODS 126casesofsepticshockpatientsinourhospitalwererandomlydi-vided into research group and control group,each were 63 cases.Research group were treated with Xuebijing intrave-nous injection treatment based on conventional therapy.Control group were treated with conventional therapy on-ly.Total effective rate,PCT and CPR before and after treatment,adverse reaction rate were compared.RESULTS The total effective rate of research group were 89.7%,which was higher than control group.The PCT and CRP of re-search group after treatment were better than control group ( P0.05).CONCLUSION Xuebijing has exact effect for septic shock.It can reduce PCT and CRP levels significantly and has no serious adverse reaction.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号